Shenqi Pharmaceutical (002332.SZ) obtains the registration certificate for domestic production of progesterone soft capsules.

Smart Finance News APP, Xianju Pharmaceutical (002332.SZ) announced that the company recently received the "Drug Registration Certificate" (Certificate Number: 2025S01275, 2025S01276) issued by the National Medical Products Administration for its progesterone soft capsules. The company's progesterone soft capsules have been approved for registration. The specifications of the company's progesterone soft capsules in this release are consistent with the specifications of the original research product that has been approved for market. It has been approved for Category 4 chemical drugs.